Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • alexbmp
    Member
    • Oct 2011
    • 30

    #1

    Strange bug(?) in GATK

    Just to see if anybody knows...

    I got this funny error(?).

    I ran GATK for chr1 (with -L chr1_startend.bed) for all of my reads in bam file,

    then I ran GATK for hg18.fa (with no -L option) for all of my reads in bam file (the same sample as when I ran GATK with only chr1;
    by the way, -L option sets the interval you want to traverse-walk with GATK,
    it's known to be completely independent between chromosomal processes).

    For chr1-only-run, I got 40,179 SNPs/indels,
    while for all-chr-run, I got 40,167 SNPs/indels.

    I've chased the read counts of chr1 in both bam file processes;

    When I start using GATK the number of reads differ between chr1-only and all-chr's processes.
    (e.g. I have 9,468,691 chr1-only-file chr1 reads after realignment,
    and 9,468,707 for all-chr-file chr1 reads; a small difference, but A difference)

    According to GATK documentations, this doesn't make any sense.

    SG works very efficiently in the GATK, provided the output of a walker is independent per site (such as the Unified Genotyper) or per chromosome (Table Recalibrator or Indel Realigner).
    (http://www.broadinstitute.org/gsa/wi...m_and_the_GATK)

    Does anybody have any ideas?

    Anyways, have a nice day all!
    Last edited by alexbmp; 12-27-2011, 10:14 PM.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 12:22 PM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
49 views
0 reactions
Last Post SEQadmin2  
Working...